Very sad and upsetting state of medical affairs... Now

New Post Public Reply Private Reply Replies (0) Message Board
DJknows PTM1 #35710
636
Very sad and upsetting state of medical affairs...

Now that there is something that even 'might' help somehow (Leronlimab) and the cat is out of the bag, if you will, people need to lobby and demand a change... if one man who happens to be President and just by saying so can get a regulatory agency to allow Hydroxychloriquine or Remdesivir (without enough trials and standards etc.) to be used across the U.S. why can't a multi-dimentional lobbying effort produce a change in this country... TO SAVE LIVES ... mind boggling...

I totally understand the clout and lobby efforts by BP but it's disgusting that over the years the industry's been given this kind of power over peoples' lives... movements in this country seem futile and I'm not sure I know what can move this needle ... and I'm afraid once we pass by this covid time it may very well go back to 'normal' on these matters of life and death...





CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

ACE Money Transfer Expands into European Markets from Ireland

Updated Category News Views 141

ACE Money Transfer's European Expansion Journey Ace Money Transfer is embarking on an exciting new adventure by expanding its services into Europe, with Ireland as its strategic base. This initiative aims to reshape the remittance landscape across the continent, building on the company's robust foundation established in Ireland. Why Ireland is the Launchpad for Growth...

Continue Reading
Legal Opportunity for BioAge Labs Investors Awaits Action

Updated Category News Views 90

Investors Prepare for Class Action Against BioAge Labs Investors in BioAge Labs, Inc. (NASDAQ: BIOA) have been alerted to an upcoming opportunity to take part in a securities class action lawsuit. This comes from the Rosen Law Firm, a global advocate for investor rights. The firm is advocating for those who purchased shares of BioAge during its initial public offering...

Continue Reading
Iveda Partners with Data Management to Advance Sustainability

Updated Category News Views 41

Iveda's Strategic Partnership to Enhance Sustainability Iveda, a leader in cloud-based AI technology, is partnering with Data Management, renowned for its expertise in disaster recovery services, to reduce carbon emissions and improve energy efficiency. This collaboration utilizes IvedaEMS, an advanced Energy Management System (EMS) that cleverly employs smart meters to...

Continue Reading
IPSEN Reports on Recent Share Buy-Back Activities in 2025

Updated Category News Views 156

Overview of IPSEN's Share Buy-Back Program IPSEN has been actively engaged in its share buy-back program, which reflects the company's commitment to maximizing shareholder value. The program is a strategic move to enhance EPS and demonstrate confidence in the business's long-term prospects. This article will delve into the specifics of transactions executed during a...

Continue Reading
Turkey's Central Bank Steadfast Amid Inflation Concerns

Updated Category News Views 72

Turkey's Central Bank Stays the Course at 50% Rate Turkey's central bank has opted to keep its policy rate steady at 50%. This decision aligns with market expectations as the institution continues to monitor inflation risks closely. Analysis of Central Bank's Position Following the monetary policy committee meeting, the central bank emphasized that the policy rate would...

Continue Reading